Intended for healthcare professionals

Letters Pharmacists’ monopoly

Changing the way pharmacy only drugs are supplied would be unwise

BMJ 2015; 351 doi: (Published 23 July 2015) Cite this as: BMJ 2015;351:h3951
  1. Claire Anderson, vice chair, English Pharmacy Board1
  1. 1Royal Pharmaceutical Society, London E1W 1AW, UK
  1. claire.anderson{at}

The move to change diclofenac from a pharmacy only drug to a prescription only one was based on safety issues, not poor advice being given by pharmacists.1 People’s expectations of pharmacies vary—from wanting in depth advice to selecting a product, buying it, and leaving with no questions asked. This takes place in an environment rooted in both health and commerce.2 There is an …

View Full Text

Log in

Log in through your institution


* For online subscription